KRKA, d.d., Novo Mesto (responsible for manufacturing 'in bulk', primary and secondary packaging, quality control and batch release) / KRKA, d.d., Novo Mesto (responsible for batch control (physical and chemical control methods))

Ukraine

All drugs from this manufacturer

  • GLICLADA

    The drug is used to treat type 2 diabetes mellitus in adults to lower and control blood glucose levels when diet and physical exercise are insufficient.

    Dosage form: tablets, modified release

    Active substance Dosage
    gliclazide 60 mg

    ATC: A10BB09

  • The drug is prescribed for adults to lower and control blood glucose levels in type 2 diabetes mellitus, if diet, physical exercise, and weight loss are insufficient.

    Dosage form: tablets, modified release

    Active substance Dosage
    gliclazide 30 mg

    ATC: A10BB09